Correlation Between Telix Pharmaceuticals and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telix Pharmaceuticals Limited and MAIA Biotechnology, you can compare the effects of market volatilities on Telix Pharmaceuticals and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and MAIA Biotechnology.
Diversification Opportunities for Telix Pharmaceuticals and MAIA Biotechnology
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Telix and MAIA is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals Limited are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Telix Pharmaceuticals and MAIA Biotechnology
Assuming the 90 days horizon Telix Pharmaceuticals Limited is expected to generate 0.58 times more return on investment than MAIA Biotechnology. However, Telix Pharmaceuticals Limited is 1.72 times less risky than MAIA Biotechnology. It trades about 0.18 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about -0.01 per unit of risk. If you would invest 1,406 in Telix Pharmaceuticals Limited on October 26, 2024 and sell it today you would earn a total of 318.00 from holding Telix Pharmaceuticals Limited or generate 22.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Telix Pharmaceuticals Limited vs. MAIA Biotechnology
Performance |
| Timeline |
| Telix Pharmaceuticals |
| MAIA Biotechnology |
Telix Pharmaceuticals and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Telix Pharmaceuticals and MAIA Biotechnology
The main advantage of trading using opposite Telix Pharmaceuticals and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Telix Pharmaceuticals vs. Genscript Biotech | Telix Pharmaceuticals vs. Keros Therapeutics | Telix Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Telix Pharmaceuticals vs. Innovent Biologics |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |